Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to elevate around Rs 4,500 crore

In Also can 2021, in a transfer to improve operational effectivity, Aurobindo Pharma had authorized the transfer of its injectable resources into a subsidiary called Eugia Pharma Specialities Miniature for “increased focal point, attention and specialization” and moreover to “elevate fund-elevate and strategic tie-united statesin future by joint ventures and tons others"

January 10, 2024 / 03:04 PM IST

Aurobindo Pharma's stock tag has risen by extra than 50 per cent in the closing six months

Aurobindo Pharma's stock tag has risen by extra than 50 p.c in the closing six months

Ashwin Mohan

Ashwin Mohan is Editor (Offers) at Moneycontrol and leads the M&A, non-public equity and equity capital market transactions coverage. He anchors the video point to 'Deal Central ' and tweets at @ashwinmohansays. He has beforehand worked with ET NOW, CNBC TV-18 and The Times of India.

Confirm Free Credit Get on Moneycontrol: With out grief observe your loans, web insights, and revel in a ₹100 cashback in your first test!

Be taught Extra

Website Designed & SEO done by KV TechMedia - Web Design Company Uttar Pradesh, India
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram